Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Ann Thorac Surg ; 113(3): 846-852, 2022 03.
Article in English | MEDLINE | ID: mdl-33878311

ABSTRACT

BACKGROUND: Patients with acute aortic dissection (AD) remain at risk for long-term complications and thus are recommended to adhere closely to American College of Cardiology and American Heart Association aorta guideline-based follow-up imaging and clinic visits. The long-term outcomes of compliance with such a model are not well understood. METHODS: This was a retrospective cohort study of patients at a regional AD center who survived hospital discharge for AD and who were analyzed by compliance with initial follow-up at 3 months and long term after AD. The primary end point was death. RESULTS: A total of 172 (66% type A; 33% type B) patients survived hospitalization and were followed up over 48 months (interquartile range [IQR], 21, 88 months). Of these patients, 122 (71%) attended the first follow-up appointment, and 90 (52%) attended more than two-thirds of recommended appointments. Patients who attended the first follow-up visit had improved long-term follow-up compliance (75% [IQR, 50%, 91%]) compared with patients who did not attend the first visit (18% [IQR, 0%, 57%]). Noncompliance with the scheduled long-term follow-up was associated with a 50% increase in the risk of death (hazard ratio, 1.6; 95% confidence interval, 1.2, 2.1; P < .001). Furthermore, in patients with low compliance (consistently attending less than one-third of follow-up appointments), the lifetime risk of death after AD was more than double that of patients with high compliance (consistently attending more than two-thirds of appointments) (hazard ratio, 2.2; 95% confidence interval, 1.5, 3.1; P < .001). CONCLUSIONS: Nearly one-third of patients with AD do not attend the first recommended follow-up visit, and such failure was associated with later noncompliance with subsequent follow-up. Low-compliant patients have double the lifetime risk of death after AD than do high-compliant patients.


Subject(s)
Aortic Dissection , Aortic Dissection/complications , Aortic Dissection/surgery , Appointments and Schedules , Follow-Up Studies , Humans , Patient Compliance , Retrospective Studies
2.
J Vasc Surg ; 75(2): 581-589.e1, 2022 02.
Article in English | MEDLINE | ID: mdl-34562569

ABSTRACT

BACKGROUND: Transcarotid artery revascularization (TCAR) is a new hybrid approach to carotid artery revascularization. Proctored training on live cases is an effort-, time-, and resource-intensive approach to learning new procedures. We analyzed the worldwide experience with TCAR to develop objective performance metrics for the procedure and compared the effectiveness of training physicians using cadavers or synthetic models to that of traditional in-person training on live cases. METHODS: Physicians underwent one of three mandatory training programs: (1) in-person proctoring on live TCAR procedures, (2) supervised training on human cadavers, and (3) supervised training on synthetic models. The training details and information from all subsequent independently performed TCAR procedures were recorded. The composite clinical adverse events (ie, transient ischemic attack, stroke, myocardial infarction, death) and composite technical adverse events (ie, aborted procedure, conversion to surgery, bleeding, dissection, cranial nerve injury, or device failure, occurring within 24 hours were recorded). Four procedural proficiency measures were recorded: procedure time, flow-reversal time, fluoroscopy time, and contrast volume. We compared the adverse event rates between the procedures performed by physicians after undergoing the three training modes and tested whether the proficiency measures achieved during TCAR after training on cadavers and synthetic models were noninferior to proctored training. RESULTS: From March 3, 2009 to May 7, 2020, 1160 physicians had undergone proctored (19.1%), cadaver-based (27.4%), and synthetic model-based (53.5%) TCAR training and had subsequently performed 17,283 TCAR procedures. The proctored physicians had treated younger patients and more patients with asymptomatic carotid stenosis and had had more prior experience with transfemoral carotid stenting. The overall 24-hour composite clinical and technical adverse event rates, adjusted for age, sex, and symptomatic status, were 1.0% (95% confidence interval, 0.8%-1.3%) and 6.0% (95% confidence interval, 5.4%-6.6%), respectively, and did not differ significantly by training mode. The proficiency measures of cadaver-trained and synthetic model-trained physicians were not inferior to those for the proctored physicians. CONCLUSIONS: We have presented key objective proficiency metrics for performing TCAR and an analytic framework to assess adequate training for the procedure. Training on cadavers or synthetic models achieved clinical outcomes, technical outcomes, and proficiency measures for subsequently performed TCAR procedures similar to those achieved with training using traditional proctoring on live cases.


Subject(s)
Carotid Arteries/surgery , Carotid Stenosis/surgery , Education, Medical, Graduate/methods , Endarterectomy, Carotid/education , Endovascular Procedures/education , Registries , Risk Assessment/methods , Aged , Aged, 80 and over , Female , Follow-Up Studies , Global Health , Hospital Mortality/trends , Humans , Male , Middle Aged , Risk Factors , Stents , Time Factors
3.
J Vasc Surg Cases Innov Tech ; 6(1): 143-146, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32154470

ABSTRACT

Retroperitoneal hematoma is a potential complication of femoral venous access that rarely leads to bilateral ureteral obstruction. We present the case of a 73-year-old woman who underwent an ablation procedure for atrial fibrillation complicated by laceration of an aberrant obturator artery during femoral venous cannulation, leading to a compressive retroperitoneal hematoma, bilateral ureteral obstruction, acute renal failure, and renal forniceal rupture. The patient was successfully treated with embolization of the inferior epigastric artery and aberrant obturator artery, hematoma evacuation, and ureteral stent placement. This case illustrates a rare complication of arterial laceration during femoral venous access without ultrasound guidance.

4.
Vasc Endovascular Surg ; 51(7): 470-479, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28859604

ABSTRACT

BACKGROUND: Aortitis is a rare condition with inflammatory or infectious etiology that can be difficult to diagnose due to the highly variable clinical presentation and nonspecific symptoms. However, current literature on the diagnosis, management, and prognosis of aortitis is extremely scarce. METHODS: We retrospectively reviewed all patients' charts who were diagnosed with giant cell arteritis, Takayasu arteritis, or noninfectious aortitis presenting at a single center between January 1, 2009, and April 17, 2015. Data collected included demographics, medical history, comorbidities, laboratory and imaging data, management, and outcome. RESULTS: Among the included 15 patients presenting with aortitis at our center, 53% were diagnosed with Takayasu arteritis, 33% with idiopathic inflammatory aortitis, and 13% with giant cell arteritis. All patients received steroid treatment, 67% received adjunctive immunosuppressants or immunomodulators, and 33% underwent interventional procedures. Based on clinical presentation and laboratory and imaging findings at the last follow-up visit for each patient, 67% showed improvement, 27% had no change in disease activity, and 7% had a progression of the disease. CONCLUSIONS: Takayasu arteritis was found to be more common than idiopathic inflammatory aortitis and giant cell arteritis among our 15 cases diagnosed with aortitis. All patients received medical therapy and 33% received interventional procedures, leading to 67% improvement of disease activity or related complications. This article also offers a comprehensive review of the diagnosis, management, and outcome of aortitis, supplementing the very limited literature on this disease.


Subject(s)
Aortitis/diagnostic imaging , Aortitis/therapy , Endovascular Procedures , Giant Cell Arteritis/diagnostic imaging , Giant Cell Arteritis/therapy , Immunosuppressive Agents/therapeutic use , Steroids/therapeutic use , Takayasu Arteritis/drug therapy , Takayasu Arteritis/therapy , Adult , Aged , Aged, 80 and over , Aortitis/epidemiology , Disease Progression , Endovascular Procedures/adverse effects , Female , Giant Cell Arteritis/epidemiology , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Minnesota/epidemiology , Remission Induction , Retrospective Studies , Steroids/adverse effects , Takayasu Arteritis/epidemiology , Time Factors , Treatment Outcome
5.
Ann Vasc Surg ; 44: 59-66, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28501665

ABSTRACT

BACKGROUND: Current recommendations suggest lifetime follow-up for endovascular aortic aneurysm repair (EVAR) patients to avoid consequences associated with endoleak and aneurysm enlargement. Follow-up compliance has been reported between 43% and 92%, with most single-center studies citing successful follow-up surveillance at less than 60%. We investigated follow-up completeness with a defined surveillance program and subsequent secondary intervention prevalence from a single center. METHODS: Our surveillance program notified patients of the need for follow-up imaging and surgeon review. Data were obtained from retrospective review of a prospective database, including operative and follow-up details, follow-up imaging completeness, endoleak incidence, and secondary intervention prevalence. RESULTS: Five hundred seventeen patients received elective EVAR from 2005 to 2015. Surveillance was achieved in 425 (82.3%). Mean number of follow-up studies was 4.2 ± 2.9 and median time to first follow-up was 36 days. Four hundred forty-eight patients (86.7%) had freedom from intervention. Sixty-nine unique patients (13.3%) had 107 secondary interventions. Median time to first secondary intervention in 69 patients was 476 days. Mean number of imaging studies for secondary intervention patients was 6.1 ± 3.9, compared with mean 3.4 ± 2.3 for patients without (P < 0.001). Overall mortality was 24.6% (n = 127), including 32 deaths of unknown cause (6.2% overall) and 95 of non-EVAR-related causes (18.3%). No aneurysm-related deaths were reported. CONCLUSIONS: Regular post-EVAR surveillance through a dedicated program resulted in a high rate of follow-up compliance, 13.3% rate of secondary intervention, and low aneurysm-related mortality. Careful lifetime surveillance remains important in long-term care following elective EVAR.


Subject(s)
Aortic Aneurysm/surgery , Blood Vessel Prosthesis Implantation , Diagnostic Imaging/methods , Endovascular Procedures , Guideline Adherence , Practice Guidelines as Topic , Practice Patterns, Physicians' , Aged , Aged, 80 and over , Aortic Aneurysm/diagnostic imaging , Aortic Aneurysm/mortality , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Diagnostic Imaging/standards , Disease-Free Survival , Endoleak/diagnostic imaging , Endoleak/etiology , Endoleak/therapy , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Guideline Adherence/standards , Humans , Kaplan-Meier Estimate , Male , Practice Guidelines as Topic/standards , Practice Patterns, Physicians'/standards , Predictive Value of Tests , Program Evaluation , Retreatment , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
6.
J Vasc Surg ; 66(2): 387-391, 2017 08.
Article in English | MEDLINE | ID: mdl-28433339

ABSTRACT

OBJECTIVE: The objective of this study was to compare snare vs the standard retrograde gate cannulation method during endovascular aneurysm repair to determine the most efficient technique and to evaluate whether time was affected by graft design or the surgeon's experience. METHODS: This was a prospective randomized study involving single-center elective endovascular aneurysm repairs. Patients were randomized to the snare or retrograde group in a 1:1 ratio. The initial method was attempted for 15 minutes; if it was unsuccessful, the team switched to the alternative technique for an additional 15 minutes. The protocol continued until success was achieved. Data collected on demographic, anatomic, and procedural factors were analyzed for statistically significant differences. RESULTS: A total of 101 patients were included. Average age was 75.3 years, and 82% were male; 49 patients were randomized to snare and 52 to retrograde cannulation. The groups were overall similar. Median cannulation times were 3.9 minutes for the snare and 2.7 minutes for the retrograde technique (P = .13). The snare group attempts were successful within the initial 15-minute period in all but one patient (98% success). In the retrograde group, 5 of the 52 (10%) crossed over to snare. This difference did not reach statistical significance (P = .11). A difference was seen in the extremes of cannulation times. The surgeon's experience and graft design were not found to have significant effects on cannulation times. Further analysis of the retrograde group patients with long cannulation time found a relative breakpoint at the 5-minute mark. In those exceeding this time mark, the chance of eventual cannulation within 15 minutes dropped to 67%. In this group, median time to cannulation was 12.2 minutes for retrograde compared with 7.1 minutes for snare after crossover. CONCLUSIONS: Gate cannulation was successful using both methods with no statistical difference between the two in median time. Retrograde cannulation was found to be more likely to have short times. If cannulation by retrograde technique had not been achieved in the first 5 minutes, the chances of eventual success dropped significantly, and crossover to snare was more efficient. This finding suggests that one should consider an alternative method of gate cannulation if it has not been accomplished within this time.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/methods , Catheterization, Peripheral/methods , Endovascular Procedures/methods , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/diagnostic imaging , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/instrumentation , Catheterization, Peripheral/adverse effects , Clinical Competence , Endovascular Procedures/adverse effects , Endovascular Procedures/instrumentation , Female , Humans , Male , Minnesota , Operative Time , Prospective Studies , Prosthesis Design , Radiography, Interventional , Risk Factors , Time Factors , Treatment Outcome
7.
Vasc Endovascular Surg ; 50(4): 286-9, 2016 May.
Article in English | MEDLINE | ID: mdl-27075991

ABSTRACT

Aortic thrombosis is a rare condition that can be caused by atherosclerosis, aneurysms, thrombophilia, vasculitis, trauma, and malignancy. Symptoms vary based on thrombus size and site of embolization. It can lead to devastating complications including acute limb ischemia, myocardial infarction, stroke, and other target organ ischemia. Diagnosis is based on clinical presentation, imaging findings, and relevant laboratory work-up. Although not well defined, management for aortic thrombosis includes surgical intervention, such as thromboembolectomy, and conservative measures, such as anticoagulation. Here, we present a unique case of aortic thrombosis causing acute lower limb ischemia with elevated lipoprotein(a) and other comorbidities. Based on our literature review, our article is the first to establish the connection between elevated lipoprotein(a) and aortic thrombosis in the nonaneurysmal aorta.


Subject(s)
Aorta, Abdominal , Aortic Diseases/blood , Arterial Occlusive Diseases/blood , Ischemia/blood , Lipoprotein(a)/blood , Lower Extremity/blood supply , Thrombosis/diagnostic imaging , Aorta, Abdominal/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortic Diseases/therapy , Aortography/methods , Arterial Occlusive Diseases/diagnostic imaging , Arterial Occlusive Diseases/therapy , Biomarkers/blood , Computed Tomography Angiography , Female , Humans , Ischemia/diagnostic imaging , Ischemia/therapy , Middle Aged , Risk Factors , Thrombosis/blood , Thrombosis/therapy , Treatment Outcome , Up-Regulation
8.
Ann Thorac Surg ; 96(2): 689-91, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23910114

ABSTRACT

Endoscopic treatment of gastroesophageal reflux disease (GERD) is emerging as an alternative to open, laparoscopic, or robotic antireflux surgical procedures. Early transoral devices failed because of poor efficacy and serious adverse events. In recent trials the EsophyX device has demonstrated acceptable safety and a reasonable efficacy profile. We present the case of a woman who experienced a distal esophageal perforation and esophagopulmonary fistula after treatment for GERD with the EsophyX device. Although considered minimally invasive, endoscopic procedures for GERD treatment can have significant deleterious consequences, and early recognition of these complications is vital to limit associated morbidity.


Subject(s)
Esophageal Fistula/etiology , Fundoplication/adverse effects , Lung Abscess/etiology , Lung Diseases/etiology , Respiratory Tract Fistula/etiology , Adult , Female , Fundoplication/instrumentation , Fundoplication/methods , Gastroesophageal Reflux/surgery , Humans , Mouth
9.
J Vasc Surg ; 53(3): 706-12, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21129907

ABSTRACT

BACKGROUND: Venous hypertension is a significant cause of patient morbidity and decreased quality of life. Common etiologies of venous hypertension include deep venous thrombosis (DVT) or congenital abnormalities resulting in chronic outflow obstruction. We have implemented an aggressive endovascular approach for the treatment of iliac venous occlusion with angioplasty and stenting. The purpose of this study was to determine the patency rates with this approach at a large tertiary care center. MATERIALS/METHODS: All patients undergoing iliofemoral venous angioplasty and stenting over a 4-year period were identified from a vascular surgical registry. Charts were reviewed retrospectively for patient demographics, the extent of venous system involvement, the time course of the venous pathology, and any underlying cause. Technical aspects of the procedure including previous angioplasty or stenting attempts and presence of collaterals on completion venogram were then recorded. Patency upon follow-up was determined using primarily ultrasound scans; other imaging methods were used if patency was not clear using an ultrasound scan. RESULTS: A total of 36 patients (40 limbs) were stented from January 2005 through December 2008. Of these patients, 27 were women (75%). Both lower extremities were involved in 4 patients. Thrombolysis was performed in 19 patients (52.8%). Thrombosis was considered acute (<30 days) in 13 patients (38%). The majority of patients who had a recognized underlying etiology were diagnosed with May-Thurner syndrome (15 patients; 42%). In 9 patients, an etiology was not determined (25%). The mean follow-up time period in the study population was 10.5 months. One stent in the study occluded acutely and required restenting. Primary patency rates at 6, 12, and 24 months were 88% (75.2-100), 78.3% (61.1-95.4), and 78.3% (61.1-95.4), respectively. Secondary patency rates for the same time frames were 100% (100.0, 100.0), 95% (85.4, 100.0), and 95% (85.4, 100.0). Better outcomes were seen in stenting for May-Thurner syndrome and idiopathic causes, whereas external compression and thrombophilia seemed to portend less favorable outcomes (P < .001). Symptomatic improvement was reported in 24 of 29 patients (83%) contacted by telephone follow-up. CONCLUSION: Iliofemoral venous stenting provides a safe and effective option for the treatment of iliac venous occlusive disease. Acceptable patency rates can be expected through short-term follow-up, especially in the case of May-Thurner syndrome. Further experience with this approach and longer-term follow-up is necessary. Thrombophilia workup should be pursued aggressively in this population, and further studies should be undertaken to determine the optimal length of anticoagulation therapy after stent placement.


Subject(s)
Angioplasty/instrumentation , Femoral Vein , Iliac Vein , Stents , Venous Thrombosis/therapy , Adolescent , Adult , Aged , Angioplasty/adverse effects , Anticoagulants/administration & dosage , Collateral Circulation , Constriction, Pathologic , Drug Administration Schedule , Female , Femoral Vein/diagnostic imaging , Femoral Vein/physiopathology , Humans , Iliac Vein/diagnostic imaging , Iliac Vein/physiopathology , Kaplan-Meier Estimate , Male , Middle Aged , Ohio , Phlebography , Proportional Hazards Models , Registries , Retrospective Studies , Risk Assessment , Risk Factors , Thrombolytic Therapy , Thrombophilia/complications , Thrombophilia/therapy , Time Factors , Treatment Outcome , Ultrasonography , Vascular Patency , Venous Thrombosis/diagnosis , Venous Thrombosis/etiology , Venous Thrombosis/physiopathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...